LVW Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
1,232
-264
-18% -$48.5K 0.02% 410
2026
Q1
$282K Buy
1,496
+115
+8% +$24.2K 0.03% 347
2025
Q4
$274K Sell
1,381
-48
-3% -$9.7K 0.03% 285
2025
Q3
$290K Buy
1,429
+204
+17% +$36.2K 0.03% 281
2025
Q2
$216K Buy
+1,225
New +$184K 0.02% 307
2015
Q3
Sell
-4,004
Closed -$232K 151
2015
Q2
$232K Buy
+4,004
New +$205K 0.1% 127
2015
Q1
Sell
-4,000
Closed -$203K 163
2014
Q4
$203K Buy
+4,000
New +$209K 0.11% 150

Other funds holding THC

LVW Advisors's THC Position: Q2 2026 in Review

LVW Advisors reduced its Tenet Healthcare (THC) stake by 18% in Q2 2026, selling an estimated $48.5K and leaving 1,232 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #410.

LVW Advisors first reported a position in THC in Q4 2014 and has held it in 7 quarters since. The position peaked at $290K in Q3 2025. 680 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • LVW Advisors held 1,232 shares of Tenet Healthcare worth $230K as of Q2 2026.
  • LVW Advisors sold 264 Tenet Healthcare shares in Q2 2026, an estimated $48.5K.
  • Tenet Healthcare made up 0.02% of LVW Advisors's portfolio in Q2 2026, its #410 holding.
  • LVW Advisors first reported a position in Tenet Healthcare in Q4 2014 and has held it in 7 quarters since.
  • LVW Advisors's Tenet Healthcare position peaked at $290K in Q3 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.